Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study to Assess the Utility of a New Innovative Technique Using Intravenous Bicarbonate to Verify the Correct Position of Patients Scheduled for Intravenous Bicarbonate

NCT01748097 is registered in ClinicalTrials.gov with Sheba Medical Center as lead sponsor.

NCT NCT01748097
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01748097 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study to Assess the Utility of a New Innovative Technique Using Intravenous Bicarbonate to Verify the Correct Position of Patients Scheduled for Intravenous Bicarbonate
Lead sponsor
Sheba Medical Center
Phase
Phase 2/3
Overall status
Unknown status
Start date
December 31, 2012
Completion date
December 31, 2013
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

detection of the correct position of intravenous line